Stay updated on Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Footer updates add Revision: v3.3.3 and remove the HHS Vulnerability Disclosure link along with Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T17:34:53.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision from v3.2.0 to v3.3.2 appears on the page, a minor update that does not affect study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:10:03.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A government funding/status notice was removed from the page. No other content changes are visible.
    Difference
    0.4%
    Check dated 2025-11-17T18:36:01.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The study details appear unchanged between the two screenshots; there are no updates to enrollment, outcomes, or contact information.
    Difference
    0.5%
    Check dated 2025-11-03T13:10:59.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Introducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-06T04:13:47.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    - Added Revision: v3.1.0. - Removed topics: MedlinePlus related topics: Drug Safety; Counterfeit Drugs; Pharmaceutical Preparations; Substandard Drugs; Revision: v3.0.2.
    Difference
    0.4%
    Check dated 2025-09-28T23:34:07.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial page.